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risk. Therefore, while this may be a possible risk, it is not a potential risk either for the healthy adult or child who gives assent. For the pregnant woman, avoiding such exposure might be viewed as one wise precautionary step among many to promote the healthy pre-and post-natal development of an offspring. Again, in the absence of data suggesting otherwise, participation in an MRI experiment cannot be portrayed as outrightly detrimental to health, as would for example, excessive alcohol or illicit drug use during pregnancy. Indeed, many advances in MRI -both structural and functional fetal MRIrely on the good will of pregnant mothers for the realization of this research and the eventual benefit they will bring to early diagnosis of disorders such as fetal growth retardation and preterm care. 3, 4 What then are the implications for disclosure? It is certainly imperative to proceed with disclosure during the process of consent that delineates well-researched, documented risks ("known risk"). It is even appropriate, as in the case of unexpected clinical findings in research for example, to cite studies of incidence rates and risks of false positives. 5 Disclosure about unknowns should be approached with extra caution. The Office of Human Research Protections of the United States Dept of Health and Human Services (http://www.hhs.gov/ohrp/ humansubjects/assurance/consentckls.htm) states that subjects are entitled to information that they should reasonably want to know (e.g., risks or discomforts). Adjudicating entitlement may not be entirely straightforward, however, given that investigators must determine reasonable risk not only from a scientific point of view but from the purview of a subject or guardian with possibly limited relevant expertise. "Absolute safety" or "absolute certainty" rarely exists, and certainly not in science that involves advanced technology. Disclosure of some unknown risks may impose unnecessary burdens on participants, such as to create unwarranted fear, a reluctance to enroll, or compromise autonomy in decision-making. 6 But indeed, what if a new risk is identified, was not initially mentioned in consent, and actually caused some harm? How do we manage already cumbersome and poorly understood consent forms in the face of increasing unknowns naturally associated with rapid innovation?
The solutions to these important questions are not simple, but the evidence to date suggests that MRI researchers have been conducting human imaging studies responsibly with respect to research ethics thus far. A rudimentary search of PubMed, with search terms such as "magnetic resonance imaging and MRI", yields more than 175,000 MRI studies of structure conducted around the world. Among these studies, approximately 66,310 concern the brain (8700 are functional brain MRI studies) for example, 8065 concern the heart, and 1384 concern the musculoskeletal system. Assuming a modest six subjects per study, we estimate roughly a million participants overall. To our knowledge there are no reports of MRI studies closed due to violations in the protection of human subjects either in consent or procedure, investigator misconduct during execution of imaging protocols, or legal action against an investigator or institution.
Increasing complexities of technique and application will inevitably accompany increasing complexities of disclosure. Ongoing, coordinated efforts among the neurological sciences, health law and biomedical ethics communities are needed to ensure that fairness both to participants and to the research enterprise is met, and that benefits of this powerful tool continue to be realized.
